新規登録 | ログイン | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

jyuh cv [182 articles]

最近 jyuh さんのライブラリに追加された論文の中から タグ cv. You can also see everyone's cv.
  • Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
    The Lancet, Vol. 362, No. 9395. (8 November 2003), pp. 1527-1535.
    posted to rct meta-analysis cv bp by jyuh on 2008-07-21 05:40:02 as **
  • Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?
    The American journal of cardiology, Vol. 100, No. 3A. (6 August 2007)
    by M Böhm
    posted to rct dual cv arb acei by jyuh on 2008-07-21 05:03:00 as **
  • Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.
    Lancet, Vol. 362, No. 9395. (8 November 2003), pp. 1527-1535.
    by F Turnbull,
    posted to rct cv bp by jyuh on 2008-07-21 02:08:46 as **
  • Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system.
    Journal of hypertension, Vol. 25, No. 5. (May 2007), pp. 951-958.
    posted to cv bp arb acei by jyuh on 2008-07-21 02:08:23 as **
  • No HOPE without proof: do ARBs meet the standard for cardiovascular protection?
    Medscape journal of medicine, Vol. 10 Suppl (2008)
    by P Sleight, A Jakobsen, J Heroys, A Ralph, T Rees, M Shaw
    posted to cv arb by jyuh on 2008-07-21 02:00:45 as **
  • Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Journal of hypertension, Vol. 26, No. 7. (July 2008), pp. 1282-1289.
    by Gianpaolo Reboldi, Fabio Angeli, Claudio Cavallini, Giorgio Gentile, Giuseppe Mancia, Paolo Verdecchia
    posted to stroke mortality meta-analysis cv arb acei by jyuh on 2008-07-21 01:49:35 as **
  • Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials.
    Journal of cardiac failure, Vol. 14, No. 3. (April 2008), pp. 181-188.
    posted to meta-analysis dual cv arb acei by jyuh on 2008-07-20 15:06:28 as **
  • Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.
    JAMA : the journal of the American Medical Association, Vol. 298, No. 3. (18 July 2007), pp. 309-316.
    by S Bansal, JE Buring, N Rifai, S Mora, FM Sacks, PM Ridker
    posted to tg gender fasting cv by jyuh on 2008-07-20 13:28:30 as **
  • Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
    JAMA, Vol. 298, No. 3. (18 July 2007), pp. 299-308.
    posted to tg mortality fasting cv cad by jyuh on 2008-07-20 13:28:12 as ** along with 1 person omalbam
  • Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study.
    BMJ (Clinical research ed.), Vol. 335, No. 7617. (1 September 2007)
    by D Conen, PM Ridker, JE Buring, RJ Glynn
    posted to gender cv bp by jyuh on 2008-07-20 13:26:04 as **
  • WITHDRAWN: Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus.
    Cochrane database of systematic reviews (Online), No. 4. (1997)
    posted to dm cv bp by jyuh on 2008-07-20 13:25:12 as **
  • Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk.
    Circulation, Vol. 115, No. 16. (24 April 2007), pp. 2145-2152.
    posted to cv abpm by jyuh on 2008-07-20 13:13:33 as **
  • Heart rate as an independent risk factor for cardiovascular disease: current evidence and basic mechanisms.
    Drugs, Vol. 67 Suppl 2 (2007), pp. 3-13.
    posted to cv by jyuh on 2008-07-19 17:16:03 as **
  • Drugs for cardiovascular disease prevention in women: implications of the AHA Guidelines--2007 Update.
    Drugs, Vol. 68, No. 3. (2008), pp. 339-358.
    by NK Wenger
    posted to guideline gender cv by jyuh on 2008-07-19 17:09:04 as **
  • Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients.
    Kidney international, Vol. 66, No. 1. (July 2004), pp. 419-427.
    by M Rao, D Guo, BL Jaber, H Tighiouart, BJ Pereira, VS Balakrishnan,
    posted to tgfb snp hd cv by jyuh on 2008-07-15 16:25:00 as **
  • Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
    Canadian journal of physiology and pharmacology, Vol. 85, No. 1. (January 2007), pp. 113-132.
    by KB Goralski, CJ Sinal
    posted to dm cv by jyuh on 2008-07-15 16:24:45 as **
  • Gene Polymorphism Association Studies in Dialysis: Cardiovascular Disease
    Seminars in Dialysis, Vol. 18, No. 3. (May 2005), pp. 217-225.
    by Madhumathi Rao, Bertrand L Jaber, Vaidyanathapuram S Balakrishnan
    posted to snp hd cv by jyuh on 2008-07-15 16:22:44 as **
  • Gene-environment interaction and oxidative stress in cardiovascular disease.
    Atherosclerosis (12 April 2008)
    by Jeffrey W W Stephens, Stephen C C Bain, Steve E E Humphries
    posted to ucp snp ros gst gene-environment cv apoe by jyuh on 2008-07-15 04:43:49 as **
  • Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review.
    American journal of epidemiology, Vol. 155, No. 6. (15 March 2002), pp. 487-495.
    by JE Eichner, ST Dunn, G Perveen, DM Thompson, KE Stewart, BC Stroehla
    posted to snp meta-analysis cv apoe by jyuh on 2008-07-15 04:40:44 as **
  • Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 52, No. 1. (July 2008), pp. 49-57.
    by EF Elsayed, H Tighiouart, DE Weiner, J Griffith, D Salem, AS Levey, MJ Sarnak
    posted to obesity cv ckd by jyuh on 2008-07-14 04:56:47 as **
  • Association of serum fetuin-A levels with mortality in dialysis patients.
    Kidney international, Vol. 72, No. 2. (July 2007), pp. 202-207.
    posted to mortality hd fetuin cv calcification by jyuh on 2008-07-14 03:04:00 as **
  • Emerging role for fetuin-A as contributor to morbidity and mortality in chronic kidney disease.
    Kidney international, Vol. 72, No. 2. (July 2007), pp. 137-140.
    posted to fetuin cv ckd calcification by jyuh on 2008-07-14 03:02:58 as **
  • VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE
    Seminars in Dialysis, Vol. 20, No. 2. (April 2007), pp. 139-143.
    posted to cv ckd calcification by jyuh on 2008-07-14 03:01:53 as **
  • Haplotype of signal transducer and activator of transcription 3 gene predicts cardiovascular disease in dialysis patients.
    Journal of the American Society of Nephrology : JASN, Vol. 17, No. 8. (August 2006), pp. 2285-2292.
    by L Zhang, WH Kao, Y Berthier-Schaad, Y Liu, L Plantinga, BG Jaar, N Fink, N Powe, MJ Klag, MW Smith, J Coresh
    posted to stat snp hd cv by jyuh on 2008-07-11 14:23:25 as **
  • Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohort.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 46, No. 1. (July 2005), pp. 78-85.
    by Y Liu, Y Berthier-Schaad, NE Fink, MD Fallin, RP Tracy, MJ Klag, MW Smith, J Coresh
    posted to snp hd fibrinogen cv by jyuh on 2008-07-11 14:23:09 as **
  • A Glu487Lys polymorphism in the gene for mitochondrial aldehyde dehydrogenase 2 is associated with myocardial infarction in elderly Korean men
    Clinica Chimica Acta, Vol. 382, No. 1-2. (July 2007), pp. 43-47.
    by Sangmee A Jo, Eun-Kyung Kim, Moon H Park, Changsu Han, Hyun-Young Park, Yangsoo Jang, Byung J Song, Inho Jo
    posted to snp cv aldh2 alcohol by jyuh on 2008-07-11 12:03:05 as **
  • Lifetime body mass index and later atherosclerosis risk in young adults: examining causal links using Mendelian randomization in the Cardiovascular Risk in Young Finns study.
    European heart journal (10 June 2008)
    by Mika Kivimäki, George Davey Smith, Nic J J Timpson, Debbie A A Lawlor, G David D Batty, Mika Kähönen, Markus Juonala, Tapani Rönnemaa, Jorma S A S Viikari, Terho Lehtimäki, Olli T T Raitakari
    posted to snp mendelian cv bmi by jyuh on 2008-07-10 11:38:04 as **
  • C-Reactive protein haplotype predicts serum C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 49, No. 1. (January 2007), pp. 118-126.
    posted to snp hd cv crp by jyuh on 2008-07-10 03:19:34 as **
  • Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.
    Canadian journal of physiology and pharmacology, Vol. 86, No. 4. (April 2008), pp. 205-209.
    posted to inflammation hd cytokine cv by jyuh on 2008-07-10 03:11:17 as **
  • C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk.
    Journal of the American College of Cardiology, Vol. 50, No. 12. (18 September 2007), pp. 1115-1122.
    by FG Hage, AJ Szalai
    posted to snp cv crp by jyuh on 2008-07-10 03:00:20 as **
  • Variants in the CRP gene as a measure of lifelong differences in average C-reactive protein levels: the Cardiovascular Risk in Young Finns Study, 1980-2001.
    American journal of epidemiology, Vol. 166, No. 7. (1 October 2007), pp. 760-764.
    posted to snp cv crp by jyuh on 2008-07-10 02:31:53 as **
  • Polymorphisms Associated with Cholesterol and Risk of Cardiovascular Events
    N Engl J Med, Vol. 358, No. 12. (20 March 2008), pp. 1240-1249.
    by Sekar Kathiresan, Olle Melander, Dragi Anevski, Candace Guiducci, Noel P Burtt, Charlotta Roos, Joel N Hirschhorn, Goran Berglund, Bo Hedblad, Leif Groop, David M Altshuler, Christopher Newton-Cheh, Marju Orho-Melander
    posted to snp lipid cv by jyuh on 2008-07-10 02:22:40 as ** along with 2 people kochhan omalbam
  • HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.
    The New England journal of medicine, Vol. 357, No. 13. (27 September 2007), pp. 1301-1310.
    by P Barter, AM Gotto, JC LaRosa, J Maroni, M Szarek, SM Grundy, JJ Kastelein, V Bittner, JC Fruchart,
    posted to lipid hdl cv by jyuh on 2008-07-10 02:22:26 as **
  • Surrogate markers, atherosclerosis and cardiovascular disease prevention
    International Journal of Clinical Practice, Vol. 62, No. 7. (July 2008), pp. 981-987.
    posted to surrogate rct cv by jyuh on 2008-07-08 08:00:53 as **
  • Cardiovascular disease in dialysis patients: do some antihypertensive drugs have specific antioxidant effects or is it just blood pressure reduction? Does antioxidant treatment reduce the risk for cardiovascular disease?
    Current opinion in nephrology and hypertension, Vol. 17, No. 1. (January 2008), pp. 99-105.
    by S Aslam
    posted to ros hd cv by jyuh on 2008-07-08 07:36:14 as **
  • Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
    JAMA : the journal of the American Medical Association, Vol. 299, No. 17. (7 May 2008), pp. 2027-2036.
    by CM Albert, NR Cook, JM Gaziano, E Zaharris, J MacFadyen, E Danielson, JE Buring, JE Manson
    posted to rct hcy gender cv by jyuh on 2008-07-08 06:44:34 as **
  • Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients
    Nephrol. Dial. Transplant. (29 May 2008), gfn304.
    by Martin Tepel, Werner Hopfenmueller, Alexandra Scholze, Alexandra Maier, Walter Zidek
    posted to hd cv ccb by jyuh on 2008-07-08 05:45:57 as **
  • Chronic Kidney Disease as a Predictor of Cardiovascular Disease (from the Framingham Heart Study).
    The American journal of cardiology, Vol. 102, No. 1. (1 July 2008), pp. 47-53.
    by NI Parikh, SJ Hwang, MG Larson, D Levy, CS Fox
    posted to rct cv ckd by jyuh on 2008-07-08 05:02:00 as **
  • Can changing antihypertensive administration time alone reduce the risk for CVD in nondipper patients with CKD?
    American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 52, No. 1. (July 2008)
    by M Fukuda
    posted to diurnal cv ckd bp abpm by jyuh on 2008-07-08 05:01:47 as **
  • Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD
    Kidney International, Vol. 67, No. 6. (June 2005), pp. 2330-2337.
    by Francesca Mallamaci, Giovanni Tripepi, Sebastiano Cutrupi, Lorenzo S Malatino, Carmine Zoccali
    posted to inflammation hd endothelial-dysfunction cv by jyuh on 2008-07-08 03:52:38 as **
  • Nutritional and anti-inflammatory interventions in chronic heart failure.
    The American journal of cardiology, Vol. 101, No. 11A. (2 June 2008)
    posted to nutrition inflammation cv by jyuh on 2008-07-06 16:41:33 as **
  • Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease.
    Internal medicine (Tokyo, Japan), Vol. 46, No. 12. (2007), pp. 807-814.
    by T Okada, T Nakao, H Matsumoto, T Shino, Y Nagaoka, R Tomaru, T Wada
    posted to mortality hd hba1c dm cv by jyuh on 2008-07-05 04:37:11 as **
  • Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 22, No. 12. (December 2007), pp. 3573-3579.
    posted to hd cv acei by jyuh on 2008-07-04 14:28:21 as **
  • Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study.
    Kidney international, Vol. 65, No. 6. (June 2004), pp. 2380-2389.
    by AK Cheung, MJ Sarnak, G Yan, M Berkoben, R Heyka, A Kaufman, J Lewis, M Rocco, R Toto, D Windus, D Ornt, AS Levey,
    posted to rct hd cv by jyuh on 2008-07-03 14:23:43 as **
  • Accuracy of anthropometric indicators of obesity to predict cardiovascular risk.
    The Journal of clinical endocrinology and metabolism, Vol. 92, No. 2. (February 2007), pp. 589-594.
    posted to obesity cv bia anthropometry by jyuh on 2008-07-01 10:47:39 as **
  • Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.
    Kidney international, Vol. 63, No. 3. (March 2003), pp. 793-808.
    posted to reverse-epidemiology hd cv by jyuh on 2008-07-01 04:10:50 as **
  • The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.
    Kidney international, Vol. 62, No. 5. (November 2002), pp. 1524-1538.
    posted to ros hd cv by jyuh on 2008-06-30 16:00:21 as **
  • Impact of inflammation on epigenetic DNA methylation a novel risk factor for cardiovascular disease?
    Journal of Internal Medicine, Vol. 261, No. 5. (May 2007), pp. 488-499.
    posted to inflammation epigenetics cv by jyuh on 2008-06-30 15:56:41 as **
  • Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients.
    Clinica chimica acta; international journal of clinical chemistry (16 June 2008)
    by Alessandro Valli, Juan J J Carrero, Abdul Rashid R Qureshi, Giacomo Garibotto, Peter Bárány, Jonas Axelsson, Bengt Lindholm, Peter Stenvinkel, Björn Anderstam, Mohamed E E Suliman
    posted to hcy cv ckd by jyuh on 2008-06-30 15:40:06 as **
  • The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
    Renal failure, Vol. 27, No. 4. (2005), pp. 403-407.
    by D Sit, AK Kadiroglu, ME Yilmaz, IH Kara, B Isikoglu
    posted to pth irs inflammation hd cv anemia by jyuh on 2008-06-30 12:39:35 as **
  • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/user/jyuh/tag/cv

    Result page: 1 2 3 4 Next RIS BibTeX RSS